Ebronucimab (Anti-PCSK9)
Ebronucimab (Anti-PCSK9) (A2843-GRP)
Products
Description
Ebronucimab (Anti-PCSK9) is a fully human immunoglobulin G1 (IgG1) monoclonal antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used to treat hyperlipidemia. MW : 144.76 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2843 |
| Target | PCSK9 |